In melanoma, the tumor microenvironment induces the upregulation of Interleukin 6 Receptor (IL-6R) and Interleukin 10 Receptor (IL-10R) on DCs, activating the STAT3 signaling pathway and suppressing the Toll-like receptor (TLR)-driven maturation program. The gene discussed is STAT3; the disease is neoplasm.